Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma
NCT01937442
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Thalidomide Celgene™
Sponsor
Celgene